CURX
Curanex Pharmaceuticals Inc
$0.29
+$0.02 (+7.72%)Today
Key Statistics
Market cap8.11M
Price-Earnings ratio—
Dividend yield—
Average volume93.09K
High today$0.30
Low today$0.27
Open price$0.27
Volume43.05K
52 Week high$9.18
52 Week low$0.26
Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.